Microba Life Sciences LimitedASX: MAP

Suspension from Quotation

· Issued by Microba Life Sciences Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Microba Life Sciences Limited has requested a voluntary suspension of its quoted securities, effective immediately, pending an announcement regarding a proposed merger. The suspension is due to concerns about the company's financial capacity to complete the merger and its cashflow position. Microba expects the suspension to last until the earlier of a specified date or the release of the relevant announcement to the market.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

The securities of Microba Life Sciences Limited (‘MAP’) will be suspended from quotation immediately under Listing Rule 17.2 at the request of MAP, pending the release of an announcement by MAP. Unless ASX decides otherwise, the securities will remain suspended until the earlier of: • the end of the period stated in MAP’s request for voluntary suspension; or • the release of the announcement to th

Microba Life Sciences Limited on 6ix

Earlier from Microba Life Sciences

All Microba Life Sciences news releases